Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Colombe

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Dermatology|July 24, 2021
The potential role of HLA typing to risk stratify melanoma patients on immunotherapy with associated SJS: pitfalls and opportunitiesElizabeth Schoenberg, Darius Mehregan, Beth Colombe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 24, 2006
The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN databaseVictor Navarro, Steven Herrine, Charles Katopes, et al.
International Journal of Dermatology|January 7, 2021
Pemphigus associated with ipilimumab therapyElizabeth Schoenberg, Beth Colombe, Jisun Cha, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 31, 2006
Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantationLiise K Kayler, John L Farber, Beth Colombe, et al.
Clinical Transplantation|November 2, 2004
Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatchLiise K Kayler, Beth Colombe, John L Farber, et al.
Blood|August 27, 2011
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosingDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage diseaseDolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2020
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on OutcomesDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Dermatology|July 24, 2021
The potential role of HLA typing to risk stratify melanoma patients on immunotherapy with associated SJS: pitfalls and opportunitiesElizabeth Schoenberg, Darius Mehregan, Beth Colombe, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 24, 2006
The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN databaseVictor Navarro, Steven Herrine, Charles Katopes, et al.
International Journal of Dermatology|January 7, 2021
Pemphigus associated with ipilimumab therapyElizabeth Schoenberg, Beth Colombe, Jisun Cha, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 31, 2006
Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantationLiise K Kayler, John L Farber, Beth Colombe, et al.
Clinical Transplantation|November 2, 2004
Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatchLiise K Kayler, Beth Colombe, John L Farber, et al.
Blood|August 27, 2011
A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosingDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 28, 2014
A two-step approach to myeloablative haploidentical transplantation: low nonrelapse mortality and high survival confirmed in patients with earlier stage diseaseDolores Grosso, Sameh Gaballa, Onder Alpdogan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2020
Low Nonrelapse Mortality after HLA-Matched Related 2-Step Hematopoietic Stem Cell Transplantation Using Cyclophosphamide for Graft-versus-Host Disease Prophylaxis and the Potential Impact of Non- Cyclophosphamide-Exposed T Cells on OutcomesDolores Grosso, Matthew Carabasi, Joanne Filicko-O'Hara, et al.
Pageof 1